Titomic Revises Indicative Schedule for US Redomiciliation
2 min read
5:32pm on Thursday 16th of July, 2026 AEST ~5pm, 16th July, 26
Titomic Limited updates investors that its planned shift of corporate domicile from Australia to the US is still underway but the timeline has slipped, with a revised schedule expected by late July or August 2026.
- Redomiciliation scheme remains in progress
- Revised timetable due late July or August
- No immediate shareholder action required
- Move aims to deepen US defense market presence
- Scheme subject to regulatory and shareholder approvals
Delayed Timeline for US Redomiciliation
Titomic Limited (ASX:TTT) has confirmed that its much-anticipated redomiciliation from Australia to the United States is still in motion but will take longer than initially expected. The company, which specialises in industrial-scale metal additive manufacturing, said it plans to release a revised indicative timetable for the scheme of arrangement by the end of July or August 2026. This adjustment pushes back the previously targeted mid-August completion.
Scheme Progress and Shareholder Implications
The redomiciliation involves transferring Titomic's corporate domicile to a newly formed Delaware corporation, Titomic, Inc., through a scheme under Part 5.1 of the Corporations Act 2001 (Cth). Shareholders are currently advised that no action is required while the company continues to work through the complex regulatory and court approvals necessary for the scheme’s implementation. The board remains committed to keeping the market informed on any material developments.
Strategic Rationale for the Move
This move is part of Titomic’s broader strategy to strengthen its footprint in the US defense and aerospace sectors, markets where it already operates from its Huntsville, Alabama headquarters. The redomiciliation is expected to provide access to deeper capital pools and potentially facilitate a US stock exchange listing, aligning with the company’s ambitions to expand its presence in key allied defense industrial bases.
Continuing Momentum in Aerospace and Defense
While the redomiciliation timeline shifts, Titomic continues to secure contracts and develop its technology. Its patented Titomic Kinetic Fusion™ cold spray technology remains central to its offerings across aerospace, defense, shipbuilding, and other industrial sectors. The company’s recent contract wins and certifications underscore its ongoing commercial traction despite the procedural delays in its corporate restructuring.
Bottom Line?
Titomic’s redomiciliation delay introduces timing uncertainty but underscores the complexity of cross-border corporate restructures in regulated sectors.
Questions in the middle?
- How will the revised timetable affect Titomic’s access to US capital markets?
- What regulatory hurdles remain before the scheme can be implemented?
- Could the delay impact ongoing contract negotiations or partnerships in the US defense sector?
